MediCor to Present at the UBS Global Life Sciences Conference
29 September 2006 - 5:00AM
PR Newswire (US)
LAS VEGAS, Sept. 28 /PRNewswire-FirstCall/ -- MediCor Ltd.
(OTC:MDCR) (BULLETIN BOARD: MDCR) , a leading manufacturer and
distributor of breast implants worldwide, today announced that
Theodore R. Maloney, its Chief Executive Officer, will be
presenting at the UBS Global Life Sciences Conference on Thursday,
September 28, 2006 at 2:00 p.m., Eastern Daylight Time in New York,
NY. A copy of the slide presentation will be available on the
Company's website at the commencement of the presentation and will
be archived on the Company's website for 30 days following the
presentation. About MediCor Ltd. MediCor was founded by Chairman of
the Board Donald K. McGhan, the pioneer of the modern day breast
implant industry. The Company acquires, develops, manufactures and
markets products for medical specialties in the aesthetic, plastic
and reconstructive surgery and dermatology markets. Products
include surgically implantable prostheses for aesthetic, plastic
and reconstructive surgery and scar management products. Its
products are sold worldwide to hospitals, surgery centers and
physicians through various distributors and direct sales personnel.
MediCor's strategy is to be the leading integrator of selected
international medical device markets, technologies and businesses.
To achieve this strategy, MediCor intends to build upon and expand
its business lines, primarily in the aesthetic, plastic and
reconstructive surgery and dermatology markets. MediCor intends to
accomplish this growth through the expansion of existing product
lines and offerings and through the acquisition of companies and
other assets, including intellectual property rights or
distribution rights. Forward-Looking Statements Additional
information about MediCor can be found on the Company's website
(http://www.medicorltd.com/) and in MediCor's Annual Report on Form
10-KSB for the year ended June 30, 2006 and subsequent quarterly
reports, all of which are filed with the Securities and Exchange
Commission and are available at the Securities and Exchange
Commission's website (http://www.sec.gov/). DATASOURCE: MediCor
Ltd. CONTACT: Marc S. Sperberg of MediCor Ltd., U.S.,
+1-702-932-4560, ext. 308 Web site: http://www.medicorltd.com/
Copyright